Investor Investigation over Takeover of Medivation Inc (NASDAQ:MDVN) by Pfizer Inc.
An investigation on behalf of investors, who currently hold shares of Medivation Inc (NASDAQ:MDVN), was announced concerning whether the takeover of Medivation Inc by Pfizer Inc. for $81.50 per share is unfair to NASDAQ:MDVN stockholders.
View full press release